New Four-Drug cocktail tested to shrink pancreatic tumors before surgery
NCT ID NCT05984602
Summary
This early-stage study is testing the safety of combining four drugs—two standard chemotherapy drugs and two newer immunotherapy drugs—to treat pancreatic cancer before surgery. The goal is to see if this combination is safe and can shrink tumors enough to allow for successful surgical removal. The study is for adults with pancreatic cancer that is confined to the pancreas and hasn't been treated yet.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ambulatory Care Center
New York, New York, 10016, United States
-
Clinical Cancer Center
New York, New York, 10016, United States
-
NYU Langone Ambulatory Care Center East 38th Street
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.